Comparative efficacy and tolerability of 32 oral and long-acting injectable antipsychotics for the maintenance treatment of adults with schizophrenia: a systematic …
J Schneider-Thoma, K Chalkou, C Dörries, I Bighelli… - The lancet, 2022 - thelancet.com
Background Schizophrenia is a common, severe, and usually chronic disorder. Maintenance
treatment with antipsychotic drugs can prevent relapse but also causes side-effects. We …
treatment with antipsychotic drugs can prevent relapse but also causes side-effects. We …
Therapeutic potential of TAAR1 agonists in schizophrenia: evidence from preclinical models and clinical studies
Trace amine-associated receptor 1 (TAAR1) has emerged as a promising therapeutic target
for neuropsychiatric disorders due to its ability to modulate monoaminergic and …
for neuropsychiatric disorders due to its ability to modulate monoaminergic and …
The clinical characterization of the patient with primary psychosis aimed at personalization of management
The current management of patients with primary psychosis worldwide is often remarkably
stereotyped. In almost all cases an antipsychotic medication is prescribed, with second …
stereotyped. In almost all cases an antipsychotic medication is prescribed, with second …
Oral and long‐acting antipsychotics for relapse prevention in schizophrenia‐spectrum disorders: a network meta‐analysis of 92 randomized trials including 22,645 …
G Ostuzzi, F Bertolini, F Tedeschi, G Vita… - World …, 2022 - Wiley Online Library
According to current evidence and guidelines, continued antipsychotic treatment is key for
preventing relapse in people with schizophrenia‐spectrum disorders, but evidence‐based …
preventing relapse in people with schizophrenia‐spectrum disorders, but evidence‐based …
Continuing, reducing, switching, or stopping antipsychotics in individuals with schizophrenia-spectrum disorders who are clinically stable: a systematic review and …
G Ostuzzi, G Vita, F Bertolini, F Tedeschi… - The Lancet …, 2022 - thelancet.com
Background Although antipsychotic maintenance treatment is widely recommended to
prevent relapse in chronic psychoses, evidence-based guidelines do not provide clear …
prevent relapse in chronic psychoses, evidence-based guidelines do not provide clear …
[HTML][HTML] From exception to the norm: how mental health interventions have become part and parcel of the humanitarian response
L Jones, P Ventevogel - World Psychiatry, 2021 - ncbi.nlm.nih.gov
Humanitarian psychiatry is the provision of services for mental health and psychosocial
support in a humanitarian context–that is, to populations exposed to collective violence …
support in a humanitarian context–that is, to populations exposed to collective violence …
[HTML][HTML] Recovery from 'schizophrenia': Perspectives of mental health nurses in the Eastern island of Indonesia
Background Recovery is a way of life to make people's lives more meaningful by working
and interacting socially in the community. The recovery has become a new vision of mental …
and interacting socially in the community. The recovery has become a new vision of mental …
Effects of mind–body exercises on schizophrenia: a systematic review with meta-analysis
Background Mind–body exercises (MBEs) have been widely accepted as a complementary
therapy for the patients with low exercise tolerance. Currently, the number of experimental …
therapy for the patients with low exercise tolerance. Currently, the number of experimental …
Five-year cumulative exposure to antipsychotic medication after first-episode psychosis and its association with 19-year outcomes
T Bergström, JJ Taskila, B Alakare… - Schizophrenia …, 2020 - academic.oup.com
Background The long-term effectiveness of antipsychotic maintenance treatment after first-
episode psychosis (FEP) is contested. In this real-world observational study, we examined …
episode psychosis (FEP) is contested. In this real-world observational study, we examined …
Verification of successful maintenance by serum drug level during a guided antipsychotic reduction to reach minimum effective dose (GARMED) trial
CI Liu, CM Liu, HH Chiu, CC Chuang… - Psychological …, 2024 - cambridge.org
BackgroundInconsistent results regarding the risk of relapse and better subjective outcomes
of previous antipsychotic dose reduction trials in patients with remitted psychosis have not …
of previous antipsychotic dose reduction trials in patients with remitted psychosis have not …